Taysha Gene Therapies Inc (TSHA)

$3.09 0.05 (1.59%)

16:00 EDT TSHA Stock Quote Delayed 30 Minutes

TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 14, 2024

TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q4 2023

7 Micro-Cap Stocks That Could Majorly Surprise Investors

More Articles

Volume:

Previous Close -

Market Cap 199.20M

PE Ratio -8.13

EPS -0.38

Volume (Avg. Vol.) 970,609

Day's Range $2.96 - $3.14

52-Week Range $0.50 - $3.89

Dividend & Yield N/A (N/A)

TSHA Stock Predictions, Articles, and Taysha Gene Therapies Inc News

From InvestorPlace
From the Web

3 Small-Cap Stocks to Sell in September Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor Sep 4, 2023

A lot of speculative companies enjoyed strong rallies in the summer. Sell these three small-cap stocks before it's too late.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 15, 2023

Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Feb 1, 2023

It's time for another look at the biggest pre-market stock movers worth checking out as we start off trading early on Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 26, 2022

It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!

What Is Going on With Taysha Gene (TSHA) Stock Today?

By Dana Blankenhorn, InvestorPlace Contributor Oct 25, 2022

Taysha and its new partner Astellas are both speculating that Adeno Associated Viruses can create treatments for genetic diseases.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Oct 25, 2022

We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!

Taysha transfers rights to 3 programs, extends cash runway into 2026 (NASDAQ:TSHA)

From Seeking Alpha Feb 15, 2024

Taysha Gene Therapies (TSHA) has transferred back the rights to three deprioritized programs and extended its cash runway into 2026 with a new loan agreement. Read more here.

3 Growth Stocks That Could Go Parabolic in 2024

From The Motley Fool Jan 15, 2024

These innovation-oriented companies could take flight this year.

Biggest stock movers today: Instacart, ARS Pharmaceuticals and more

From Seeking Alpha Sep 20, 2023

Stock futures are trading near the flatline in the early hours of Wednesday as market players prepare for the second day of the Fed&amp;#39;s policy meeting.Here are some of Wednesd

Taysha Gene Therapies ceases development of neurology drug TSHA-120 (TSHA)

From Seeking Alpha Sep 19, 2023

Taysha Gene Therapies (TSHA) is discontinuing development of its drug candidate TSHA-120 for the treatment of giant axonal neuropathy due to study design problems. Read more here.

2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?

From The Motley Fool Sep 19, 2023

These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?

Taysha Gene Therapies (TSHA) Gets a Buy from JMP Securities

From TipRanks Nov 10, 2022

In a report released today, Silvan Tuerkcan from JMP Securities maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report), with a price target...

ADVERTISEMENT